MTPConnect is Australia’s Life Sciences Innovation Accelerator – an independent, not-for-profit organisation established in 2015 to champion Australia’s life sciences sector by:
Visit our Going Global page to find out more…
Find out more about our innovation programs.
MTPConnect forges stronger connections between research and industry to help maximize opportunities for Australians to not only make scientific and technological breakthroughs, but to see them developed through the proof-of-concept stage and successfully translated and commercialised.
We achieve these outcomes with a focus on improving collaborations and commercialisation, funding cutting-edge innovations, improving management and workforce skills, optimising the regulatory and policy environment and improving access to global supply chains and strategic international markets.
MTPConnect also operates accelerator programs to support the development of cutting-edge medical technology, biotechnology and pharmaceutical innovations, with more than A$166 million invested so far in 213 projects.
MTPConnect is guided by an experienced Board of Directors, managed by a professional executive team with expert staff based around Australia. The national MTPConnect team brings experiences in industry, technology transfer, medical device/pharmaceutical commercialisation, venture capital, project management, clinical trials, international trade and investment, government and the public sector, governance, policy and media and communications.
Undertaking highly targeted actions to foster connections and collaboration.
Listening to the sector to provide an independent voice to shape policy and regulatory renewal, and influence the direction of funding.
Jointly funding targeted sector-led projects to address identified constraints and gaps.
With its focus on increasing collaboration and commercialisation, MTPConnect has been able to draw on multiple industry partners to secure matching industry contributions and substantial flow-on industry investment to amplify grant funding and help drive projects through the early stages of clinical development and maximise the chances for commercialisation success.
MTPConnect’s investments, combined additional contributions from industry of $192.2 million, flow-on external investment of $1.1 billion and the $452 million from successful grant reviews, have contributed to more than $1.9 billion flowing into Australia’s medical products sector.
The overall economic impact of MTPConnect’s activities, calculated by applying a benefit-cost ratio to reflect the wider economic benefits of medical research, shows a total attributable return of ~$7.5 billion. (Annual Report 2024)
MTPConnect continues to be an important innovation accelerator supporting the development and translation of Australia’s health and medical research into valuable and clinically important medical products.
The popular MTPConnect Podcast series connects you with the people and the issues driving Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.
Launched in February 2019, the series features hundreds of guests including notable scientists, physicians, entrepreneurs and business leaders. Now in its seventh season with 200 episodes, the show has had more than 65,000 downloads. Available on all podcast platforms including Apple Podcasts, Google podcasts, and Spotify with listeners in Australia and internationally.
Listen to the PodcastDeveloping new medical devices and therapeutics is widely recognised as a formidable challenge – it is risky, expensive and commercial returns can take decades to be realised.
MTPConnect has continued its work across FY2024 supporting Australia’s life science innovators to meet the commercialisation challenge, providing funding through our accelerator programs, building sector capabilities and cementing collaborations between industry and research to help bring life-saving medical products from bench to bedside.
In nine years of operation, MTPConnect Is firmly established as Australia’s life sciences innovation accelerator.
